The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/. The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
PARP1 protein affects the reaction [hydroquinone results in increased expression of AATF protein] hydroquinone results in increased ADP-ribosylation of AATF protein
hydroquinone results in increased expression of ADAM17 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of ADAM17 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA]; ADAM17 protein affects the reaction [hydroquinone results in increased secretion of TNF protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; MIR122 mRNA affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; MIR122 mRNA affects the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased expression of ADAM17 protein]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA]
hydroquinone affects the localization of AHR protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of and affects the localization of AHR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of AHR protein]; hydroquinone results in increased expression of and affects the localization of AHR protein alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of AHR protein]
hydroquinone inhibits the reaction [AKT1 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of AKT1 protein]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of and results in increased activity of AKT1 protein] 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of AKT1 protein]
hydroquinone results in decreased expression of APOE mRNA [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of APOE mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of APOE mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of APOE mRNA]
hydroquinone results in increased expression of ARNT protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ARNT protein]
hydroquinone results in increased phosphorylation of ATF2 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of ATF2 protein]; ATF2 protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; ATF2 protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of TNF protein]; hydroquinone promotes the reaction [ATF2 protein binds to MIR122 promoter]; hydroquinone promotes the reaction [ATF2 protein binds to PPP2CA promoter]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased phosphorylation of ATF2 protein]
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ATF6 protein]; [Sirolimus co-treated with hydroquinone] results in decreased expression of ATF6 protein; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of ATF6 protein]; ATF6 protein affects the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; ATF6 protein affects the reaction [hydroquinone results in increased expression of BAX protein]; ATF6 protein affects the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein] hydroquinone results in decreased expression of ATF6 mRNA; hydroquinone results in decreased expression of ATF6 protein
PARP1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mRNA]; SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of ATG5 mRNA]
[ferric chloride results in increased oxidation of hydroquinone] promotes the reaction [hydroquinone analog binds to BACH1 protein]; hydroquinone promotes the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of BACH1 protein] hydroquinone results in decreased expression of BACH1 protein hydroquinone affects the localization of BACH1 protein
hydroquinone results in decreased expression of BAX protein hydroquinone results in increased expression of BAX protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of BAX protein]; 4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [hydroquinone results in increased expression of BAX protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of BAX protein]; [ABT-737 co-treated with hydroquinone] results in increased expression of BAX protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of BAX protein]; ATF6 protein affects the reaction [hydroquinone results in increased expression of BAX protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of BAX protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of BAX protein]; Sirolimus promotes the reaction [hydroquinone results in increased expression of BAX protein]
[PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein; [PARP1 protein co-treated with hydroquinone] results in increased expression of BCL2 protein; CDKN2A protein affects the reaction [hydroquinone results in increased expression of BCL2 protein]; PARP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 protein] hydroquinone results in decreased expression of BCL2 mRNA; hydroquinone results in decreased expression of BCL2 protein hydroquinone promotes the reaction [XBP1 protein affects the expression of BCL2 mRNA]; XBP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 mRNA] hydroquinone results in increased expression of BCL2 mRNA; hydroquinone results in increased expression of BCL2 protein
hydroquinone results in increased expression of BECN1 mRNA; hydroquinone results in increased expression of BECN1 protein PARP1 protein promotes the reaction [hydroquinone results in increased expression of BECN1 mRNA]; SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of BECN1 mRNA]
hydroquinone results in increased cleavage of BID protein FADD protein affects the reaction [hydroquinone results in increased cleavage of BID protein]
hydroquinone results in decreased expression of BIRC5 protein Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of BIRC5 protein]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC protein]; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC protein; BTRC protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]; BTRC protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of SP1 protein]; Chloroquine inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA]; Dactinomycin promotes the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of BTRC mRNA]
hydroquinone results in increased cleavage of CASP1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP1 protein]
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of CASP12 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of CASP12 protein]
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of and affects the activity of CASP3 protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of CASP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein]; hydroquinone results in decreased expression of and results in increased cleavage of CASP3 protein; IGF1 protein inhibits the reaction [hydroquinone results in increased expression of CASP3 protein modified form]; Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP3 protein modified form]; NOX4 protein promotes the reaction [hydroquinone results in increased degradation of CASP3 protein]; Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP3 protein]; PARP1 protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein] hydroquinone results in decreased activity of CASP3 protein [hydroquinone results in increased abundance of Reactive Oxygen Species] which results in decreased activity of CASP3 protein hydroquinone results in decreased expression of CASP3 mRNA; hydroquinone results in decreased expression of CASP3 protein
hydroquinone results in increased cleavage of CASP7 protein hydroquinone results in increased expression of CASP7 protein modified form hydroquinone results in decreased activity of CASP7 protein Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP7 protein modified form]; WRN protein inhibits the reaction [hydroquinone results in increased cleavage of CASP7 protein]
FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein]; MPO protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein]; Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP8 protein] hydroquinone results in increased expression of CASP8 protein hydroquinone results in increased activity of CASP8 protein
hydroquinone results in decreased expression of CASP9 mRNA; hydroquinone results in decreased expression of CASP9 protein hydroquinone results in increased activity of CASP9 protein hydroquinone results in increased expression of CASP9 protein Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of CASP9 protein modified form]; Okadaic Acid inhibits the reaction [hydroquinone results in increased cleavage of CASP9 protein]
hydroquinone results in decreased secretion of CCL2 protein hydroquinone results in decreased expression of CCL2 mRNA hydroquinone inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 mRNA]; hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CCL2 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased secretion of CCL2 protein] hydroquinone results in increased secretion of CCL2 protein hydroquinone results in increased expression of CCL2 protein
Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of CCND1 protein] hydroquinone results in increased expression of CCND1 mRNA; hydroquinone results in increased expression of CCND1 protein
hydroquinone results in increased expression of CD86 protein hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of CD86 protein]
hydroquinone results in increased expression of CDKN1A mRNA; hydroquinone results in increased expression of CDKN1A protein SIRT1 protein affects the reaction [hydroquinone results in increased expression of CDKN1A protein]
CDKN2A protein affects the reaction [hydroquinone results in decreased expression of BAX protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of RB1 protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of TP53 protein]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of BCL2 protein]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of MMP9 mRNA]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of MMP9 protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of CDKN2A protein] hydroquinone results in decreased expression of CDKN2A mRNA; hydroquinone results in decreased expression of CDKN2A protein
CNMD protein results in increased susceptibility to hydroquinone hydroquinone results in increased expression of CNMD mRNA Dactinomycin inhibits the reaction [hydroquinone results in increased expression of CNMD protein]; hydroquinone results in increased expression of and results in increased secretion of CNMD protein; NQO1 protein inhibits the reaction [CNMD protein results in increased susceptibility to hydroquinone]; NQO1 protein inhibits the reaction [hydroquinone results in increased expression of CNMD protein]
hydroquinone results in increased expression of COL1A1 protein [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]
[COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased expression of and results in increased secretion of TNF protein; [COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased secretion of IL1B protein; [COL2A1 protein co-treated with hydroquinone] results in increased expression of IL6 protein
hydroquinone results in decreased expression of COL4A1 mRNA hydroquinone results in increased expression of COL4A1 protein [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of CREB1 protein]; CREB1 protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; CREB1 protein affects the reaction [hydroquinone results in increased expression of TNF protein]; hydroquinone promotes the reaction [CREB1 protein binds to PPP2CA promoter]
[CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK3 protein hydroquinone results in decreased secretion of CSF2 protein hydroquinone promotes the reaction [[CSF2 protein co-treated with Lipopolysaccharides] results in increased abundance of Nitric Oxide]
hydroquinone inhibits the reaction [CTNNB1 protein binds to LEF1 protein]; hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein; IGF1 protein inhibits the reaction [hydroquinone results in decreased expression of CTNNB1 protein]; Lithium Chloride inhibits the reaction [hydroquinone results in decreased expression of CTNNB1 protein]; PPP2CA protein affects the reaction [hydroquinone affects the localization of CTNNB1 protein]; PPP2CA protein affects the reaction [hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; PPP2R5A protein affects the reaction [hydroquinone affects the localization of CTNNB1 protein]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]
hydroquinone affects the localization of CYCS protein hydroquinone results in increased expression of CYCS protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of CYCS protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of CYCS protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYCS protein]
CYP1A1 protein affects the susceptibility to hydroquinone 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of CYP1A1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of CYP1A1 protein] hydroquinone results in increased expression of CYP1A1 mRNA; hydroquinone results in increased expression of CYP1A1 protein
[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone; [CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone; [Glutathione co-treated with [CYP2E1 protein results in increased metabolism of Phenol]] results in increased chemical synthesis of [Glutathione binds to hydroquinone metabolite]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone] hydroquinone results in increased expression of CYP2E1 mRNA Resveratrol inhibits the reaction [hydroquinone results in increased expression of CYP2E1 mRNA] hydroquinone results in increased expression of CYP2E1 mRNA; hydroquinone results in increased expression of CYP2E1 protein [CYP2E1 protein affects the metabolism of Benzene] which affects the chemical synthesis of hydroquinone; PPP2CA protein affects the reaction [hydroquinone results in increased expression of CYP2E1 protein]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of CYP2E1 mRNA]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of CYP2E1 protein]
hydroquinone results in increased expression of DDIT3 mRNA; hydroquinone results in increased expression of DDIT3 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; hydroquinone results in increased expression of and affects the localization of DDIT3 protein; ursodoxicoltaurine inhibits the reaction [hydroquinone results in increased expression of and affects the localization of DDIT3 protein]; XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein] [XBP1 protein affects the susceptibility to hydroquinone] which affects the expression of DDIT3 protein; hydroquinone promotes the reaction [XBP1 protein affects the expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 protein]
hydroquinone results in decreased expression of DNMT1 mRNA; hydroquinone results in decreased expression of DNMT1 protein hydroquinone results in increased expression of DNMT1 mRNA hydroquinone affects the expression of DNMT1 mRNA
hydroquinone results in decreased expression of DNMT3A mRNA; hydroquinone results in decreased expression of DNMT3A protein hydroquinone affects the expression of DNMT3A mRNA hydroquinone results in increased expression of DNMT3A mRNA
hydroquinone results in decreased expression of DNMT3B mRNA Decitabine affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]; trichostatin A affects the reaction [hydroquinone affects the expression of DNMT3B mRNA]
hydroquinone results in increased expression of E4F1 mRNA; hydroquinone results in increased expression of E4F1 protein E4F1 protein affects the susceptibility to hydroquinone [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of H2AX protein modified form; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of RB1 protein; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of RB1 protein modified form
hydroquinone results in increased phosphorylation of EIF2AK3 protein hydroquinone results in increased expression of EIF2AK3 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of EIF2AK3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of EIF2AK3 protein]
ELAVL1 protein inhibits the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; ELAVL1 protein inhibits the reaction [hydroquinone results in decreased expression of SIRT3 protein]; ELAVL1 protein inhibits the reaction [hydroquinone results in increased degradation of SIRT3 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 protein]; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 mRNA] hydroquinone results in increased degradation of ELAVL1 mRNA hydroquinone results in decreased expression of ELAVL1 mRNA; hydroquinone results in decreased expression of ELAVL1 protein
[[NOX4 protein results in decreased expression of ELAVL2 protein] which promotes the reaction SIDT2 protein] promotes the reaction [hydroquinone results in decreased degradation of SIRT3 protein]
EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Benzene] which results in increased chemical synthesis of hydroquinone]; EPHX1 protein promotes the reaction [[CYP2E1 protein results in increased metabolism of Phenol] which results in increased chemical synthesis of hydroquinone]
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of ERN1 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of ERN1 protein]
hydroquinone results in decreased expression of FADD mRNA FADD protein affects the reaction [hydroquinone results in increased cleavage of BID protein]; FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein]; FADD protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein]
hydroquinone results in increased expression of FAS protein [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of FAS protein
FAU protein affects the reaction [hydroquinone results in increased expression of and results in increased activity of NQO1 protein]; FAU protein affects the reaction [hydroquinone results in increased expression of H2AX protein]
hydroquinone results in decreased expression of FOS mRNA hydroquinone results in increased phosphorylation of FOS protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of FOS protein]; FOS protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; FOS protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; hydroquinone promotes the reaction [FOS protein binds to MIR122 promoter]
hydroquinone results in decreased expression of GATA1 mRNA Decitabine inhibits the reaction [hydroquinone inhibits the reaction [Hemin results in increased expression of GATA1 mRNA]]; hydroquinone inhibits the reaction [GATA1 protein binds to HBA1 gene]; hydroquinone inhibits the reaction [GATA1 protein binds to HBD gene]; hydroquinone inhibits the reaction [GATA1 protein binds to HBG1 gene]; hydroquinone inhibits the reaction [Hemin results in increased expression of GATA1 mRNA]
hydroquinone affects the reaction [Hemin affects the expression of GATA2 mRNA]; hydroquinone inhibits the reaction [Hemin results in decreased expression of GATA2 protein]; hydroquinone promotes the reaction [GATA2 protein binds to HBB gene]; hydroquinone promotes the reaction [GATA2 protein binds to HBG2 gene]; hydroquinone promotes the reaction [GATA2 protein binds to HBM gene]; hydroquinone promotes the reaction [GATA2 protein binds to HBP1 gene]; hydroquinone promotes the reaction [Hemin results in decreased expression of GATA2 mRNA] hydroquinone results in decreased expression of GATA2 mRNA
hydroquinone results in increased expression of GCLC mRNA; hydroquinone results in increased expression of GCLC protein [hydroquinone affects the methylation of GCLC promoter] which results in decreased abundance of 5-Methylcytosine; [hydroquinone affects the methylation of GCLC promoter] which results in increased abundance of 5-hydroxymethylcytosine; Resveratrol promotes the reaction [hydroquinone results in increased expression of GCLC mRNA]; TET1 protein affects the reaction [hydroquinone results in increased expression of GCLC mRNA]
hydroquinone results in increased expression of GSDMD protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of GSDMD protein]
hydroquinone results in increased expression of and results in decreased phosphorylation of and results in increased activity of GSK3B protein; IGF1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of GSK3B protein]; Lithium Chloride inhibits the reaction [hydroquinone results in increased expression of GSK3B protein]
hydroquinone results in increased expression of GSS protein NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of GSS protein]
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; [ABT-737 co-treated with hydroquinone] results in increased expression of H2AX protein; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of H2AX protein modified form; [SIRT1 protein affects the susceptibility to hydroquinone] which affects the expression of H2AX protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of H2AX protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of H2AX protein]; POLH protein affects the reaction [hydroquinone results in increased expression of H2AX protein]; WRN gene mutant form promotes the reaction [hydroquinone results in increased expression of H2AX protein alternative form]; WRN protein affects the reaction [hydroquinone results in increased expression of H2AX protein] FAU protein affects the reaction [hydroquinone results in increased expression of H2AX protein] hydroquinone results in increased phosphorylation of H2AX protein hydroquinone affects the localization of H2AX protein modified form hydroquinone results in increased expression of H2AX protein; hydroquinone results in increased expression of H2AX protein alternative form
Decitabine inhibits the reaction [hydroquinone inhibits the reaction [Hemin results in increased expression of HBB mRNA]]; hydroquinone inhibits the reaction [Hemin results in increased expression of HBB mRNA]; hydroquinone promotes the reaction [GATA2 protein binds to HBB gene] hydroquinone results in decreased methylation of HBB promoter
hydroquinone results in increased expression of HDAC1 mRNA; hydroquinone results in increased expression of HDAC1 protein trichostatin A inhibits the reaction [hydroquinone results in increased expression of HDAC1 mRNA]
hydroquinone results in increased expression of HDAC2 mRNA; hydroquinone results in increased expression of HDAC2 protein trichostatin A inhibits the reaction [hydroquinone results in increased expression of HDAC2 mRNA]
decitabine inhibits the reaction [hydroquinone inhibits the reaction [Hemin results in increased expression of HMBS mRNA]]; hydroquinone inhibits the reaction [Hemin results in increased expression of HMBS mRNA]
hydroquinone results in increased expression of HMOX1 mRNA; hydroquinone results in increased expression of HMOX1 protein 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; AG 1879 inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; bisindolylmaleimide I inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Cysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Dithiothreitol inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein]; SB 203580 inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Staurosporine inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Staurosporine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; Wortmannin inhibits the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; Wortmannin inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein] 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]; [Resveratrol co-treated with hydroquinone] results in increased expression of HMOX1 protein; ferric chloride promotes the reaction [hydroquinone results in increased expression of HMOX1 protein]; NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein]; Resveratrol promotes the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; risuteganib promotes the reaction [hydroquinone results in increased expression of HMOX1 mRNA]; risuteganib promotes the reaction [hydroquinone results in increased expression of HMOX1 protein]; S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of HMOX1 protein]
Decitabine affects the reaction [hydroquinone affects the expression of HOTAIRM1 mRNA]; Decitabine affects the reaction [hydroquinone affects the methylation of HOTAIRM1 promoter]; trichostatin A affects the reaction [hydroquinone affects the expression of HOTAIRM1 mRNA]; trichostatin A affects the reaction [hydroquinone affects the methylation of HOTAIRM1 promoter]
3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of HRAS protein]; Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of HRAS protein]; hydroquinone promotes the reaction [PARP1 protein binds to and results in increased ADP-ribosylation of and results in increased expression of HRAS protein]; PARP1 protein promotes the reaction [hydroquinone results in increased expression of HRAS protein] hydroquinone affects the expression of HRAS mRNA; hydroquinone affects the expression of HRAS protein
hydroquinone results in increased expression of HSPA5 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of HSPA5 protein]
hydroquinone inhibits the reaction [[IFNG protein co-treated with lipopolysaccharide, E. coli O26-B6] results in increased secretion of CCL2 protein]; hydroquinone inhibits the reaction [Amino Acids, Peptides, and Proteins results in increased expression of IFNG protein]; IFNG protein promotes the reaction [[Lipopolysaccharides co-treated with hydroquinone] results in increased abundance of Nitric Oxide]
IGF1 protein inhibits the reaction [hydroquinone results in decreased expression of CTNNB1 protein]; IGF1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of GSK3B protein]; IGF1 protein inhibits the reaction [hydroquinone results in increased expression of CASP3 protein modified form]
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL10 mRNA] hydroquinone results in increased secretion of IL10 protein hydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of IL10 protein]
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL12B mRNA] hydroquinone results in increased expression of IL12B mRNA
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased secretion of IL18 protein]
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased cleavage of IL1A protein] Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of IL1A protein]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]]; PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein] hydroquinone results in increased expression of IL1A mRNA; hydroquinone results in increased expression of IL1A protein hydroquinone results in decreased cleavage of IL1A protein
hydroquinone results in decreased cleavage of IL1B protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of and results in increased secretion of IL1B protein]; hydroquinone results in increased expression of and results in increased secretion of IL1B protein hydroquinone results in increased expression of IL1B mRNA hydroquinone results in decreased secretion of IL1B protein [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of IL1B mRNA; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein] [COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased secretion of IL1B protein; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL1B protein]
hydroquinone promotes the reaction [keyhole-limpet hemocyanin results in increased expression of IL4 mRNA]; hydroquinone promotes the reaction [keyhole-limpet hemocyanin results in increased expression of IL4 protein]
[COL2A1 protein co-treated with hydroquinone] results in increased expression of IL6 protein; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] [hydroquinone co-treated with TNF protein] results in increased secretion of IL6 protein hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of IL6 protein] hydroquinone results in decreased secretion of IL6 protein
hydroquinone inhibits the reaction [AKT1 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [AKT2 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [AKT3 protein results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased phosphorylation of IRF3 protein]; hydroquinone inhibits the reaction [TICAM1 protein results in increased phosphorylation of IRF3 protein]
hydroquinone results in decreased activity of ITGB1 protein hydroquinone results in decreased expression of ITGB1 mRNA hydroquinone results in decreased expression of ITGB1 protein
hydroquinone results in decreased expression of ITGB2 protein hydroquinone results in decreased expression of ITGB2 mRNA hydroquinone results in increased expression of ITGB2 protein
hydroquinone affects the localization of JUN protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased phosphorylation of JUN protein]; hydroquinone promotes the reaction [JUN protein binds to MIR122 promoter]; hydroquinone promotes the reaction [JUN protein binds to PPP2CA promoter]; JUN protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 mRNA]; JUN protein affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; JUN protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; JUN protein affects the reaction [hydroquinone results in increased expression of TNF protein]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased phosphorylation of JUN protein]
KMT2A mutant form results in decreased susceptibility to hydroquinone [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of APP mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of FABP4 mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of IL1B mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of KLF4 mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of LPL mRNA; [KMT2A mutant form results in decreased susceptibility to hydroquinone] which results in increased expression of PPARG mRNA
[PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of KRAS protein hydroquinone results in increased expression of KRAS protein hydroquinone affects the expression of KRAS mRNA
hydroquinone results in increased expression of LAMA4 protein [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]
[hydroquinone co-treated with Hemin] affects the expression of MAGI1 mRNA; [hydroquinone co-treated with Hemin] affects the expression of MAGI1 protein; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A protein]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RASSF5 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RASSF5 protein]
Chloroquine inhibits the reaction [hydroquinone results in increased degradation of MAP1LC3A protein]; hydroquinone affects the localization of and results in increased degradation of MAP1LC3A protein
hydroquinone results in increased lipidation of MAP1LC3B protein 4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; ATF6 protein affects the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Chloroquine promotes the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]; Sirolimus promotes the reaction [hydroquinone results in increased lipidation of MAP1LC3B protein]
MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein]; MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK3 protein]; MAP2K1 protein inhibits the reaction [hydroquinone results in increased expression of PPP2CA protein]
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein]; [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK1 protein; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in decreased phosphorylation of MAPK1 protein; hydroquinone results in increased phosphorylation of and results in increased activity of MAPK1 protein; MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK1 protein] hydroquinone results in increased phosphorylation of MAPK1 protein
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [hydroquinone results in increased phosphorylation of and results in increased activity of MAPK3 protein]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK3 protein]; [CSF2 protein co-treated with hydroquinone] results in increased phosphorylation of and results in increased activity of MAPK3 protein; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in decreased phosphorylation of MAPK3 protein; hydroquinone results in increased phosphorylation of and results in increased activity of MAPK3 protein; MAP2K1 protein inhibits the reaction [hydroquinone results in decreased phosphorylation of MAPK3 protein] hydroquinone results in increased phosphorylation of MAPK3 protein
hydroquinone results in increased phosphorylation of MAPK8 protein hydroquinone results in decreased expression of and results in increased phosphorylation of MAPK8 protein
hydroquinone results in decreased expression of MBD2 mRNA PARP1 protein affects the reaction [hydroquinone results in increased expression of MBD2 protein]
hydroquinone results in increased expression of MCL1 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]; [hydroquinone co-treated with WEHI-539] results in decreased expression of MCL1 protein; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein; PMAIP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]; SP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]
ATF2 protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; FOS protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; hydroquinone promotes the reaction [ATF2 protein binds to MIR122 promoter]; hydroquinone promotes the reaction [FOS protein binds to MIR122 promoter]; hydroquinone promotes the reaction [JUN protein binds to MIR122 promoter]; JUN protein affects the reaction [hydroquinone results in decreased expression of MIR122 mRNA]; MIR122 mRNA affects the reaction [hydroquinone results in decreased expression of and results in increased secretion of TNF protein]; MIR122 mRNA affects the reaction [hydroquinone results in increased expression of ADAM17 protein]; MIR122 mRNA affects the reaction [hydroquinone results in increased expression of and results in increased stability of ADAM17 mRNA]
hydroquinone affects the expression of MIR146A mRNA hydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in increased expression of MIR146A mRNA]; MIR146A mRNA affects the reaction [hydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of TRAF6 protein]]
Doxorubicin promotes the reaction [hydroquinone results in increased expression of MIR155 mRNA]; PARP1 protein affects the reaction [hydroquinone results in increased expression of MIR155 mRNA]; trichostatin A promotes the reaction [hydroquinone results in increased expression of MIR155 mRNA]
hydroquinone results in decreased expression of MIR25; hydroquinone results in decreased expression of MIR25 mRNA [hydroquinone results in decreased expression of MIR25] which results in increased expression of NOX4 protein; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of MIR25]
hydroquinone affects the reaction [[Hemin co-treated with MIR486-1 mRNA] affects the expression of RASSF5 mRNA]; hydroquinone inhibits the reaction [Hemin results in increased expression of MIR486-1 mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A protein]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]
[MMP14 protein co-treated with TIMP2 protein] inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]; [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]; MMP14 protein inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; MMP14 protein inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]
hydroquinone results in decreased activity of MMP2 protein [MMP14 protein co-treated with TIMP2 protein] inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]; MMP14 protein inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]
CDKN2A protein affects the reaction [hydroquinone results in increased expression of MMP9 mRNA]; CDKN2A protein affects the reaction [hydroquinone results in increased expression of MMP9 protein]; hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]]; hydroquinone promotes the reaction [TNF protein results in increased secretion of MMP9 protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of MMP9 mRNA]; PARP1 protein inhibits the reaction [hydroquinone results in increased expression of MMP9 protein]; pyrazolanthrone inhibits the reaction [hydroquinone results in increased secretion of MMP9 protein]; SB 203580 inhibits the reaction [hydroquinone results in increased secretion of MMP9 protein] hydroquinone results in increased expression of MMP9 mRNA; hydroquinone results in increased expression of MMP9 protein
[trichostatin A co-treated with Decitabine] promotes the reaction [hydroquinone results in increased expression of MPL mRNA]; Decitabine promotes the reaction [hydroquinone results in increased expression of MPL mRNA] hydroquinone results in decreased methylation of MPL gene
[[[MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone] which results in increased chemical synthesis of quinone] which results in decreased activity of PTPN2 protein; [[MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone] which results in increased chemical synthesis of quinone; [MPO protein co-treated with Hydrogen Peroxide] promotes the reaction [hydroquinone results in decreased activity of TOP2A protein]; [MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone; [MPO protein results in increased hydroxylation of Phenol] which results in increased chemical synthesis of hydroquinone; MPO protein affects the reaction [hydroquinone results in increased cleavage of CASP8 protein] MPO protein results in increased chemical synthesis of hydroquinone MPO protein results in increased oxidation of hydroquinone
[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in increased expression of MT2A mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of MT2A mRNA]
hydroquinone results in decreased phosphorylation of MTOR protein 4,6-dimorpholino-N-(4-nitrophenyl)-1,3,5-triazin-2-amine inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; ATF6 protein affects the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]; Sirolimus promotes the reaction [hydroquinone results in decreased phosphorylation of MTOR protein]
hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of MYC protein] hydroquinone results in decreased expression of MYC mRNA
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of and affects the localization of NFE2L2 protein]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein]; 2-tert-butylhydroquinone promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased activity of NFE2L2 promoter]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein]; ferric chloride promotes the reaction [hydroquinone results in increased expression of NFE2L2 protein]; hydroquinone affects the localization of and results in increased degradation of NFE2L2 protein; hydroquinone inhibits the reaction [benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased ubiquitination of NFE2L2 protein]; hydroquinone promotes the reaction [NFE2L2 protein binds to SRC protein]; hydroquinone results in increased expression of and affects the localization of NFE2L2 protein; NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of GSS protein]; NFE2L2 mRNA affects the reaction [hydroquinone results in increased expression of HMOX1 protein]; S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of NFE2L2 protein] hydroquinone results in increased expression of NFE2L2 mRNA; hydroquinone results in increased expression of NFE2L2 protein hydroquinone results in decreased expression of NFE2L2 mRNA
hydroquinone results in decreased activity of [NFKB1 protein binds to RELA protein] hydroquinone results in decreased expression of NFKB1 mRNA hydroquinone results in increased expression of NFKB1 protein
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased phosphorylation of NFKBIA protein] hydroquinone affects the phosphorylation of NFKBIA protein hydroquinone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]
hydroquinone results in increased expression of NLRP3 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of NLRP3 protein]
hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 protein] hydroquinone results in increased expression of NOS2 mRNA hydroquinone results in decreased expression of NOS2 mRNA; hydroquinone results in decreased expression of NOS2 protein
[[NOX4 protein results in decreased expression of ELAVL2 protein] which promotes the reaction SIDT2 protein] promotes the reaction [hydroquinone results in decreased degradation of SIRT3 protein]; [hydroquinone co-treated with WEHI-539] results in increased expression of NOX4 protein; [hydroquinone results in decreased expression of MIR25] which results in increased expression of NOX4 protein; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in increased expression of NOX4 mRNA; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in increased expression of NOX4 protein; [WEHI-539 co-treated with hydroquinone] results in increased expression of NOX4 mRNA; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 protein]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of SIRT3 protein]; NOX4 protein promotes the reaction [hydroquinone results in increased degradation of CASP3 protein]; NOX4 protein promotes the reaction [hydroquinone results in increased degradation of PARP1 protein]; SIDT2 protein promotes the reaction [hydroquinone results in increased expression of NOX4 mRNA] hydroquinone results in increased expression of NOX4 mRNA; hydroquinone results in increased expression of NOX4 protein
hydroquinone results in increased expression of NQO1 mRNA; hydroquinone results in increased expression of NQO1 protein FAU protein affects the reaction [hydroquinone results in increased expression of and results in increased activity of NQO1 protein]; hydroquinone results in increased expression of and results in increased activity of NQO1 protein NQO1 protein results in decreased susceptibility to hydroquinone ferric chloride promotes the reaction [hydroquinone results in increased expression of NQO1 protein]; hydroquinone results in increased expression of and results in increased activity of NQO1 protein; NQO1 protein inhibits the reaction [CNMD protein results in increased susceptibility to hydroquinone]; NQO1 protein inhibits the reaction [hydroquinone results in increased expression of CNMD protein]; S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of NQO1 protein]
hydroquinone results in increased cleavage of PARP1 protein hydroquinone results in increased degradation of PARP1 protein hydroquinone results in decreased expression of PARP1 protein PARP1 protein affects the susceptibility to hydroquinone hydroquinone results in increased expression of PARP1 protein PARP1 protein results in increased susceptibility to hydroquinone hydroquinone affects the expression of PARP1 protein 3-aminobenzamide inhibits the reaction [hydroquinone results in increased expression of PARP1 protein]; [ABT-737 co-treated with hydroquinone] results in increased cleavage of PARP1 protein; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of and affects the activity of CASP3 protein; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of BCL2 protein; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of FAS protein; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of KRAS protein; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of TP53 protein; [PARP1 protein co-treated with hydroquinone] results in increased expression of BCL2 protein; ABT-737 inhibits the reaction [hydroquinone affects the localization of PARP1 protein]; Doxorubicin inhibits the reaction [hydroquinone results in decreased expression of PARP1 protein]; hydroquinone promotes the reaction [PARP1 protein binds to and results in increased ADP-ribosylation of and results in increased expression of HRAS protein]; hydroquinone results in increased expression of and affects the localization of PARP1 protein; hydroquinone results in increased expression of and results in increased cleavage of PARP1 protein; Lithium Chloride inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein]; NOX4 protein promotes the reaction [hydroquinone results in increased degradation of PARP1 protein]; PARP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 protein]; PARP1 protein affects the reaction [hydroquinone results in decreased expression of TJP2 mRNA]; PARP1 protein affects the reaction [hydroquinone results in increased cleavage of CASP3 protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of AATF protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of H2AX protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of MBD2 protein]; PARP1 protein affects the reaction [hydroquinone results in increased expression of MIR155 mRNA]; PARP1 protein affects the reaction [hydroquinone results in increased expression of MMP9 mRNA]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of BAX protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of CDKN2A protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of RB1 protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of TP53 protein]; PARP1 protein inhibits the reaction [hydroquinone results in increased expression of MMP9 protein]; PARP1 protein promotes the reaction [hydroquinone results in increased expression of ATG5 mRNA]; PARP1 protein promotes the reaction [hydroquinone results in increased expression of BECN1 mRNA]; PARP1 protein promotes the reaction [hydroquinone results in increased expression of HRAS protein]; WRN protein inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein]
Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased abundance of Reactive Oxygen Species]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]]; PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased abundance of Reactive Oxygen Species]; PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of IL1A protein]; PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]; [hydroquinone co-treated with WEHI-539] results in increased expression of PMAIP1 protein; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 mRNA; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein; BTRC protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]; mithramycin A inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 mRNA]; mithramycin A inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]; PMAIP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]; SP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]
POLH protein affects the reaction [hydroquinone results in increased expression of H2AX protein] POLH protein affects the susceptibility to hydroquinone
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of PPP2CA protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; Chloroquine inhibits the reaction [hydroquinone results in increased expression of PPP2CA protein]; CREB1 protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; hydroquinone promotes the reaction [ATF2 protein binds to PPP2CA promoter]; hydroquinone promotes the reaction [CREB1 protein binds to PPP2CA promoter]; hydroquinone promotes the reaction [JUN protein binds to PPP2CA promoter]; JUN protein affects the reaction [hydroquinone results in increased expression of PPP2CA protein]; MAP2K1 protein inhibits the reaction [hydroquinone results in increased expression of PPP2CA protein]; PPP2CA protein affects the reaction [hydroquinone affects the localization of CTNNB1 protein]; PPP2CA protein affects the reaction [hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; PPP2CA protein affects the reaction [hydroquinone results in increased expression of CYP2E1 protein]
PPP2R5A protein affects the reaction [hydroquinone affects the localization of CTNNB1 protein]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of and results in decreased phosphorylation of CTNNB1 protein]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of CYP2E1 mRNA]; PPP2R5A protein affects the reaction [hydroquinone results in increased expression of CYP2E1 protein]
[[[MPO protein co-treated with Hydrogen Peroxide] results in increased metabolism of hydroquinone] which results in increased chemical synthesis of quinone] which results in decreased activity of PTPN2 protein
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of PYCARD protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased expression of PYCARD protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of PYCARD protein]
[hydroquinone co-treated with Hemin] affects the expression of RAP1A mRNA; [hydroquinone co-treated with Hemin] affects the expression of RAP1A protein; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A protein]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAP1A protein]
[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA; [hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 mRNA]; MIR486-1 mRNA affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RAPGEF2 protein]
[hydroquinone co-treated with Hemin] affects the expression of RASSF5 mRNA; [hydroquinone co-treated with Hemin] affects the expression of RASSF5 protein; hydroquinone affects the reaction [[Hemin co-treated with MIR486-1 mRNA] affects the expression of RASSF5 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RASSF5 mRNA]; MAGI1 protein affects the reaction [[hydroquinone co-treated with Hemin] affects the expression of RASSF5 protein]
hydroquinone results in increased expression of RB protein hydroquinone results in decreased expression of RB1 mRNA; hydroquinone results in decreased expression of RB1 protein [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of RB1 protein; [E4F1 protein affects the susceptibility to hydroquinone] which results in decreased expression of RB1 protein modified form; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of RB1 protein]; hydroquinone results in decreased expression of and results in increased phosphorylation of RB1 protein; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of RB1 protein]
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; 4-phenylbutyric acid inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; Acetylcysteine inhibits the reaction [hydroquinone results in increased phosphorylation of RELA protein]; hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of and affects the localization of RELA protein]; hydroquinone inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein] hydroquinone affects the localization of RELA protein hydroquinone inhibits the reaction [Lipopolysaccharides affects the localization of RELA protein]; hydroquinone results in decreased activity of [NFKB1 protein binds to RELA protein]
hydroquinone affects the methylation of SFN promoter hydroquinone results in increased expression of SFN mRNA [hydroquinone affects the methylation of SFN promoter] which results in decreased abundance of 5-Methylcytosine; [hydroquinone affects the methylation of SFN promoter] which results in increased abundance of 5-hydroxymethylcytosine; TET1 protein affects the reaction [hydroquinone results in increased expression of SFN mRNA]
hydroquinone results in increased expression of SIDT2 protein [[NOX4 protein results in decreased expression of ELAVL2 protein] which promotes the reaction SIDT2 protein] promotes the reaction [hydroquinone results in decreased degradation of SIRT3 protein]; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of ELAVL1 mRNA]; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of MIR25]; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; SIDT2 protein promotes the reaction [hydroquinone results in increased expression of NOX4 mRNA]
[SIRT1 protein affects the susceptibility to hydroquinone] which affects the expression of H2AX protein; SIRT1 protein affects the reaction [hydroquinone results in increased expression of CDKN1A protein]; SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of ATG5 mRNA]; SIRT1 protein inhibits the reaction [hydroquinone results in increased expression of BECN1 mRNA] hydroquinone affects the expression of SIRT1 mRNA; hydroquinone affects the expression of SIRT1 protein
hydroquinone results in decreased expression of SIRT3 mRNA; hydroquinone results in decreased expression of SIRT3 protein [[NOX4 protein results in decreased expression of ELAVL2 protein] which promotes the reaction SIDT2 protein] promotes the reaction [hydroquinone results in decreased degradation of SIRT3 protein]; Chloroquine inhibits the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; Chloroquine inhibits the reaction [hydroquinone results in decreased expression of SIRT3 protein]; ELAVL1 protein inhibits the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; ELAVL1 protein inhibits the reaction [hydroquinone results in decreased expression of SIRT3 protein]; ELAVL1 protein inhibits the reaction [hydroquinone results in increased degradation of SIRT3 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; NOX4 protein promotes the reaction [hydroquinone results in decreased expression of SIRT3 protein]; SIDT2 protein promotes the reaction [hydroquinone results in decreased expression of SIRT3 mRNA]; SIRT3 protein inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]
hydroquinone results in decreased activity of SOD1 protein S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of SOD1 protein] hydroquinone results in decreased expression of SOD1 mRNA
hydroquinone results in decreased activity of SOD2 protein S-allylcysteine inhibits the reaction [hydroquinone results in increased expression of SOD2 protein] hydroquinone results in decreased expression of SOD2 mRNA
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of SP1 protein]; [hydroquinone co-treated with WEHI-539] results in increased expression of SP1 protein; [WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of SP1 protein; BTRC protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of SP1 protein]; SP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in decreased expression of MCL1 protein]; SP1 protein affects the reaction [[WEHI-539 co-treated with venetoclax co-treated with hydroquinone] results in increased expression of PMAIP1 protein]
hydroquinone results in decreased expression of SQSTM1 protein 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [[venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in decreased expression of SQSTM1 protein]; [venetoclax co-treated with WEHI-539 co-treated with hydroquinone] results in decreased expression of SQSTM1 protein; Chloroquine inhibits the reaction [hydroquinone results in increased degradation of SQSTM1 protein]; hydroquinone results in increased degradation of and results in decreased expression of SQSTM1 protein
AG 1879 inhibits the reaction [hydroquinone results in increased phosphorylation of SRC protein] hydroquinone promotes the reaction [NFE2L2 protein binds to SRC protein]
hydroquinone results in decreased expression of TET1 mRNA hydroquinone results in increased expression of and results in increased activity of TET1 protein; TET1 protein affects the reaction [hydroquinone results in increased expression of GCLC mRNA]; TET1 protein affects the reaction [hydroquinone results in increased expression of SFN mRNA] [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TET1 mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TET1 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of TET1 mRNA]
hydroquinone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of TFRC protein]; hydroquinone promotes the reaction [Hemin results in decreased expression of TFRC mRNA] hydroquinone results in decreased expression of TFRC protein
[MMP14 protein co-treated with TIMP2 protein] inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]; [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; [TIMP2 protein co-treated with MMP14 protein] inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in decreased activity of MMP2 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of COL1A1 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of COL4A1 protein]; TIMP2 protein inhibits the reaction [hydroquinone results in increased expression of LAMA4 protein] hydroquinone results in decreased expression of TIMP2 mRNA [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP2 mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP2 mRNA]
hydroquinone results in decreased expression of TIMP3 mRNA [[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP3 mRNA; Acetylcysteine inhibits the reaction [[[Cadmium Chloride results in increased abundance of Cadmium] which co-treated with hydroquinone] results in decreased expression of TIMP3 mRNA]; Acetylcysteine inhibits the reaction [hydroquinone results in decreased expression of TIMP3 mRNA]
4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [hydroquinone results in increased expression of TNF protein]; [hydroquinone co-treated with TNF protein] results in increased secretion of CXCL8 protein; [hydroquinone co-treated with TNF protein] results in increased secretion of IL6 protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of TNF protein]; Acetylcysteine promotes the reaction [PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]]; ADAM17 protein affects the reaction [hydroquinone results in increased secretion of TNF protein]; ATF2 protein affects the reaction [hydroquinone results in increased expression of TNF protein]; benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [hydroquinone results in increased expression of TNF protein]; Chloroquine inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; CREB1 protein affects the reaction [hydroquinone results in increased expression of TNF protein]; hydroquinone inhibits the reaction [[Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in increased expression of TNF protein]; hydroquinone inhibits the reaction [Dicumarol inhibits the reaction [TNF protein results in increased expression of and results in increased secretion of MMP9 protein]]; hydroquinone inhibits the reaction [TNF protein results in increased phosphorylation of CHUK protein]; hydroquinone inhibits the reaction [TNF protein results in increased phosphorylation of NFKBIA protein]; hydroquinone inhibits the reaction [TNF protein results in increased phosphorylation of RELA protein]; hydroquinone promotes the reaction [TNF protein results in increased secretion of MMP9 protein]; hydroquinone results in decreased expression of and results in increased secretion of TNF protein; hydroquinone results in increased expression of and results in increased secretion of TNF protein; hydroquinone results in increased expression of and results in increased stability of TNF mRNA; JUN protein affects the reaction [hydroquinone results in increased expression of TNF protein]; MIR122 mRNA affects the reaction [hydroquinone results in decreased expression of and results in increased secretion of TNF protein]; N-((2-(hydroxyaminocarbonyl)methyl)-4-methylpentanoyl)-3-(2'-naphthyl)alanylalanine, 2-aminoethylamide inhibits the reaction [hydroquinone results in decreased expression of and results in increased secretion of TNF protein]; Okadaic Acid inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; Okadaic Acid inhibits the reaction [hydroquinone results in increased expression of TNF protein]; PIK3R1 protein modified form inhibits the reaction [hydroquinone results in increased expression of TNF protein]; SIRT3 protein inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; ZFP36 protein inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; ZFP36 protein inhibits the reaction [hydroquinone results in increased expression of TNF protein] hydroquinone results in increased expression of TNF mRNA; hydroquinone results in increased expression of TNF protein hydroquinone results in decreased activity of TNF protein [COL2A1 protein co-treated with Freund's Adjuvant co-treated with hydroquinone] results in increased expression of and results in increased secretion of TNF protein; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] [hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride; Chlorpromazine inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride]; Chlorpromazine inhibits the reaction [hydroquinone results in increased expression of TNF protein]; Cromolyn Sodium inhibits the reaction [[hydroquinone results in increased expression of TNF protein] which results in increased susceptibility to Methacholine Chloride]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased expression of TNF protein]; hydroquinone inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]; hydroquinone metabolite inhibits the reaction [[Lipopolysaccharides co-treated with Galactosamine] results in increased expression of TNF protein]
hydroquinone results in increased expression of TNFRSF1B protein hydroquinone results in increased expression of TNFRSF1B mRNA alpha-naphthoflavone inhibits the reaction [hydroquinone results in increased expression of TNFRSF1B protein]
hydroquinone affects the activity of TOP2A protein hydroquinone results in decreased activity of TOP2A protein [MPO protein co-treated with Hydrogen Peroxide] promotes the reaction [hydroquinone results in decreased activity of TOP2A protein]
hydroquinone results in increased expression of TP53 protein; hydroquinone results in increased expression of TRP53 protein hydroquinone affects the expression of TP53 protein hydroquinone results in decreased expression of TP53 mRNA; hydroquinone results in decreased expression of TP53 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [hydroquinone results in increased expression of TP53 protein]; 2-tert-butylhydroquinone inhibits the reaction [hydroquinone results in increased expression of TP53 protein]; [ABT-737 co-treated with hydroquinone] results in increased expression of TRP53 protein; [PARP1 protein affects the susceptibility to hydroquinone] which affects the expression of TP53 protein; Acetylcysteine inhibits the reaction [hydroquinone results in increased expression of TP53 protein]; CDKN2A protein affects the reaction [hydroquinone results in decreased expression of TP53 protein]; PARP1 protein inhibits the reaction [hydroquinone results in decreased expression of TP53 protein]; WRN protein affects the reaction [hydroquinone results in increased acetylation of TP53 protein]; WRN protein affects the reaction [hydroquinone results in increased expression of TP53 protein]
hydroquinone results in decreased expression of TRAF6 mRNA; hydroquinone results in decreased expression of TRAF6 protein hydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of TRAF6 mRNA]; hydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of TRAF6 protein]; MIR146A mRNA affects the reaction [hydroquinone promotes the reaction [Tetradecanoylphorbol Acetate results in decreased expression of TRAF6 protein]]
hydroquinone results in increased activity of TRPA1 protein [hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium; Dithiothreitol inhibits the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; Dithiothreitol inhibits the reaction [hydroquinone results in increased activity of TRPA1 protein]; mustard oil promotes the reaction [[hydroquinone results in increased activity of TRPA1 protein] which results in increased import of Calcium]; mustard oil promotes the reaction [hydroquinone results in increased activity of TRPA1 protein]
WRN gene mutant form promotes the reaction [hydroquinone results in increased expression of H2AX protein alternative form]; WRN protein affects the reaction [hydroquinone results in increased acetylation of TP53 protein]; WRN protein affects the reaction [hydroquinone results in increased expression of H2AX protein]; WRN protein affects the reaction [hydroquinone results in increased expression of TP53 protein]; WRN protein inhibits the reaction [hydroquinone results in increased cleavage of CASP7 protein]; WRN protein inhibits the reaction [hydroquinone results in increased cleavage of PARP1 protein] WRN protein results in decreased susceptibility to hydroquinone WRN gene mutant form results in increased susceptibility to hydroquinone
[XBP1 protein affects the susceptibility to hydroquinone] which affects the expression of DDIT3 protein; hydroquinone promotes the reaction [XBP1 protein affects the expression of BCL2 mRNA]; hydroquinone promotes the reaction [XBP1 protein affects the expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in decreased expression of BCL2 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 mRNA]; XBP1 protein affects the reaction [hydroquinone results in increased expression of DDIT3 protein] hydroquinone results in decreased expression of XBP1 protein alternative form Resveratrol inhibits the reaction [hydroquinone results in increased expression of XBP1 protein]; XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased expression of DDIT3 protein]; XBP1 protein alternative form inhibits the reaction [hydroquinone results in increased phosphorylation of EIF2S1 protein] hydroquinone results in increased splicing of XBP1 mRNA
benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [hydroquinone results in decreased expression of ZFP36 protein]; Chloroquine inhibits the reaction [hydroquinone results in decreased expression of ZFP36 protein]; Okadaic Acid inhibits the reaction [hydroquinone results in decreased expression of ZFP36 protein]; ZFP36 protein inhibits the reaction [hydroquinone results in increased expression of TNF mRNA]; ZFP36 protein inhibits the reaction [hydroquinone results in increased expression of TNF protein]
Arbutin results in decreased expression of HSD3B1 mRNA Arbutin results in decreased expression of HSD3B1 mRNA; Arbutin results in decreased expression of HSD3B1 protein
Arbutin results in decreased activity of SRD5A1 protein Arbutin results in decreased expression of SRD5A1 mRNA; Arbutin results in decreased expression of SRD5A1 protein
monobenzone results in increased activity of NR1I2 protein [monobenzone results in increased activity of NR1I2 protein] which results in increased expression of CYP3A4 mRNA
TET1 protein affects the reaction [2,3,5,6-tetrachlorohydroquinone results in increased chemical synthesis of 5-hydroxymethylcytosine]; TET1 protein affects the reaction [2,3,5,6-tetrachlorohydroquinone results in increased oxidation of 5-Methylcytosine]
TET2 protein affects the reaction [2,3,5,6-tetrachlorohydroquinone results in increased chemical synthesis of 5-hydroxymethylcytosine]; TET2 protein affects the reaction [2,3,5,6-tetrachlorohydroquinone results in increased oxidation of 5-Methylcytosine]